arrow
Back
S

Sheela Rao

morgan stanley children's hospital

9H-index
36Paper Count
360Citation Count
Published Papers 7
Publication Date
Maintenance durvalumab after fi rst-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study
err2024-07-01
err0
errOAAI
errFong, C.; Patel, B.; Peckitt, C.; Bourmpaki, E.; Satchwell, L.; Cromarty, S.; Kidd, S.; von Loga, K.; Uhlik, M.; Begum, R.; Rana, T.; Waddell, T.; Darby, S.; Bradshaw, A.; Roques, T.; Morgan, C.; Rees, C.; Herbertson, R.; Das, P.; Thompson, C.; Hewish, M.; Petty, R.; Thistlethwaite, F.; Rao, S.; Starling, N.; Chau, I.; Cunningham, D.
errShare
errSave
Predictive biomarkers and protein specific mismatch repair (MMR) loss in gastrointestinal (GI) tumours on immune checkpoint inhibitors (ICI): Correlation with survival
err2024-06-01
err0
PREAI
errLe, H. M. L.; Paiva, R. V. D. S.; Farag, S.; Dadouli, K.; Ntellas, P.; Cunningham, D.; Starling, N.; Rao, S.; Fribbens, C.; Chau, I.
errShare
errSave
Acquired resistance to first-line chemo- and EGFRab-therapy in mCRC: Biopsy analysis of the iSCORE trial
err2024-06-01
err0
PREAI
errLane, R.; Mencel, J.; Turkes, F.; Challoner, B. R.; McCafferty, N.; Ntellas, P.; Barber, L. J.; Rana, I.; Chen, H-C.; Begum, R.; Ficial, M.; Tran, A.; Terlizzo, M.; Rao, S.; Cunningham, D.; Chau, I.; Starling, N.; Gerlinger, M.
errShare
errSave
EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma
err2022-06-01
err0
errOAAI
errSlater, S.; Cartwright, E.; Saffery, C.; Tran, A.; Smith, G.; Bacason, M.; Zhitkov, O.; Rana, I.; Johnston, E.; Sanna, I.; Aresu, M.; Kohoutova, D.; Terlizzo, M.; Turkes, F.; Smyth, E.; Mansoor, W.; Fribbens, C.; Rao, S.; Watkins, D.; Starling, N.; Chau, I.; Cunningham, D.
errShare
errSave
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy
err2016-12-01
err25
errOAAI
errMoore, M.; Gill, S.; Asmis, T.; Berry, S.; Burkes, R.; Zbuk, K.; Alcindor, T.; Jeyakumar, A.; Chan, T.; Rao, S.; Spratlin, J.; Tang, P. A.; Rothenstein, J.; Chan, E.; Bendell, J.; Kudrik, F.; Kauh, J.; Tang, S.; Gao, L.; Kambhampati, S. R. P.; Nasroulah, F.; Yang, L.; Ramdas, N.; Binder, P.; Strevel, E.
errShare
errSave
Childhood Poverty and Its Effect on Health and Well-being: Enhancing Training for Learners Across the Medical Education Continuum
err2016-04-01
err17
errOAAI
errChamberlain, Lisa J.; Hanson, Elizabeth R.; Klass, Perri; Schickedanz, Adam; Nakhasi, Ambica; Barnes, Michelle M.; Berger, Susan; Boyd, Rhea W.; Dreyer, Benard P.; Meyer, Dodi; Navsaria, Dipesh; Rao, Sheela; Klein, Melissa
errShare
errSave